查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1714331

DNA 聚合酶市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、應用、最終用途、地區和競爭細分，2020-2030 年預測

DNA Polymerase Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type, By Application, By End-use, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球 DNA 聚合酶市場價值為 1.3367 億美元，預計到 2030 年將達到 1.7599 億美元，預測期內複合年成長率為 4.65%。 DNA聚合酶是催化DNA合成的必需酶，在細胞複製和遺傳訊息傳遞中起著關鍵作用。這些酵素是 PCR、DNA 定序、克隆和診斷等關鍵生物技術過程的基礎。市場成長的動力來自於分子技術在研究和臨床診斷中的日益普及、傳染病和遺傳疾病的盛行率上升以及人們對個人化醫療的興趣日益濃厚。基因研究的不斷進步以及合成生物學和精準醫療等新興領域對高性能酵素的需求激增，進一步推動了市場的發展。

市場概覽
預測期 2026-2030
2024年市場規模 1.3367億美元
2030年市場規模 1.7599億美元
2025-2030 年複合年成長率 4.65%
成長最快的領域 Taq聚合酶
最大的市場 北美洲

關鍵市場促進因素

法醫和農業生物技術的發展

主要市場挑戰

市場飽和與競爭

主要市場趨勢

客製化DNA聚合酶

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球 DNA 聚合酶市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按類型（Taq 聚合酶、Pfu 聚合酶、專有酵素混合物）
    • 按應用（聚合酶鍊式反應、DNA定序、DNA克隆、其他）
    • 按最終用途（製藥和生物技術公司、學術和研究機構、醫院和診斷中心、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美DNA聚合酶市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲DNA聚合酶市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區 DNA 聚合酶市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：南美DNA聚合酶市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東與非洲 DNA 聚合酶市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球 DNA 聚合酶市場：SWOT 分析

第 14 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章：競爭格局

  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies.
  • Merck KGaA.
  • Danaher Corp.
  • QIAGEN NV
  • Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc.
  • Takara Bio, Inc.
  • Promega Corporation.
  • New England Biolabs

第 16 章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 16101

The Global DNA Polymerase Market was valued at USD 133.67 million in 2024 and is projected to reach USD 175.99 million by 2030, growing at a CAGR of 4.65% during the forecast period. DNA polymerases are essential enzymes that catalyze the synthesis of DNA, playing a critical role in cellular replication and genetic information transfer. These enzymes are fundamental to key biotechnological processes including PCR, DNA sequencing, cloning, and diagnostics. Market growth is being driven by increasing adoption of molecular techniques in research and clinical diagnostics, rising prevalence of infectious and genetic diseases, and growing interest in personalized medicine. The ongoing advancements in genetic studies and the surge in demand for high-performance enzymes in emerging fields like synthetic biology and precision medicine are further propelling the market.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 133.67 Million
Market Size 2030USD 175.99 Million
CAGR 2025-20304.65%
Fastest Growing SegmentTaq Polymerase
Largest MarketNorth America

Key Market Drivers

Growth of Forensic and Agricultural Biotechnology

The expansion of forensic and agricultural biotechnology is significantly driving demand for DNA polymerases. In forensic science, DNA polymerase is vital for amplifying trace DNA through PCR, enabling identification in criminal investigations, paternity testing, and disaster victim recovery. High-performance enzymes that can amplify low-quality or degraded samples are particularly crucial. With law enforcement agencies enhancing digital records and reducing DNA testing backlogs globally, demand for reliable, high-fidelity polymerases continues to grow. Emerging regions, such as Asia-Pacific and Latin America, are modernizing their forensic systems, creating B2G contract opportunities and increasing adoption of forensic-grade reagents. Government-supported initiatives, such as U.S. assistance to Pakistan's forensic modernization, reflect a broader commitment to improving global forensic capabilities. Additionally, in agricultural biotechnology, DNA polymerases are used for plant genotyping and GMO testing, further boosting market growth across diverse application areas.

Key Market Challenges

Market Saturation and Competition

The DNA polymerase market faces intense competition and saturation due to the presence of numerous manufacturers offering similar enzyme variants. This competitive pressure leads to price reductions, which can diminish profit margins and hinder investments in R&D. As the market becomes more commoditized, distinguishing products based on performance and innovation becomes challenging, especially when customers prioritize cost over quality. This environment discourages smaller or newer companies from entering the market, while established players benefit from brand loyalty, economies of scale, and long-term relationships with customers. The difficulty of switching suppliers due to validation costs and reliability concerns further entrenches existing market leaders, limiting room for differentiation and slowing innovation.

Key Market Trends

Customized DNA Polymerases

The market is witnessing a strong trend toward customized DNA polymerases tailored to meet specific experimental or diagnostic needs. These enzymes are engineered for attributes such as high fidelity, resistance to inhibitors, and improved processivity-making them suitable for applications in cutting-edge technologies like single-cell genomics, next-generation sequencing, and CRISPR-based editing. Customized polymerases enhance data quality and reproducibility, which is especially important in precision medicine and molecular diagnostics. Their versatility enables application across pharmaceutical, clinical, academic, and biotechnological sectors. As demand grows for tailored genetic analysis tools, customized DNA polymerases are increasingly viewed as essential reagents for advancing research and therapeutic innovation, expanding their footprint in both academic and commercial domains.

Key Market Players

  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies
  • Merck KGaA
  • Danaher Corp.
  • QIAGEN N.V.
  • Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc.
  • Takara Bio, Inc.
  • Promega Corporation
  • New England Biolabs

Report Scope:

In this report, the Global DNA Polymerase Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

DNA Polymerase Market, By Type:

  • Taq Polymerase
  • Pfu Polymerase
  • Proprietary Enzyme Blends

DNA Polymerase Market, By Application:

  • Polymerase Chain Reaction
  • DNA Sequencing
  • DNA Cloning
  • Others

DNA Polymerase Market, By End Use:

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Hospitals & Diagnostic Centers
  • Others

DNA Polymerase Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global DNA Polymerase Market.

Available Customizations:

Global DNA Polymerase market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global DNA Polymerase Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Taq Polymerase, Pfu Polymerase, Proprietary Enzyme Blends)
    • 5.2.2. By Application (Polymerase Chain Reaction, DNA Sequencing, DNA Cloning, Others)
    • 5.2.3. By End-use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America DNA Polymerase Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type (Taq Polymerase, Pfu Polymerase, Proprietary Enzyme Blends)
    • 6.2.2. By Application (Polymerase Chain Reaction, DNA Sequencing, DNA Cloning, Others)
    • 6.2.3. By End-use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers, Others)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States DNA Polymerase Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End-use
    • 6.3.2. Canada DNA Polymerase Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End-use
    • 6.3.3. Mexico DNA Polymerase Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End-use

7. Europe DNA Polymerase Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type (Taq Polymerase, Pfu Polymerase, Proprietary Enzyme Blends)
    • 7.2.2. By Application (Polymerase Chain Reaction, DNA Sequencing, DNA Cloning, Others)
    • 7.2.3. By End-use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers, Others)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France DNA Polymerase Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End-use
    • 7.3.2. Germany DNA Polymerase Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End-use
    • 7.3.3. United Kingdom DNA Polymerase Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End-use
    • 7.3.4. Italy DNA Polymerase Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End-use
    • 7.3.5. Spain DNA Polymerase Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End-use

8. Asia-Pacific DNA Polymerase Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type (Taq Polymerase, Pfu Polymerase, Proprietary Enzyme Blends)
    • 8.2.2. By Application (Polymerase Chain Reaction, DNA Sequencing, DNA Cloning, Others)
    • 8.2.3. By End-use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers, Others)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China DNA Polymerase Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End-use
    • 8.3.2. India DNA Polymerase Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End-use
    • 8.3.3. Japan DNA Polymerase Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End-use
    • 8.3.4. South Korea DNA Polymerase Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End-use
    • 8.3.5. Australia DNA Polymerase Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End-use

9. South America DNA Polymerase Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type (Taq Polymerase, Pfu Polymerase, Proprietary Enzyme Blends)
    • 9.2.2. By Application (Polymerase Chain Reaction, DNA Sequencing, DNA Cloning, Others)
    • 9.2.3. By End-use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers, Others)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil DNA Polymerase Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End-use
    • 9.3.2. Argentina DNA Polymerase Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End-use
    • 9.3.3. Colombia DNA Polymerase Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End-use

10. Middle East and Africa DNA Polymerase Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type (Taq Polymerase, Pfu Polymerase, Proprietary Enzyme Blends)
    • 10.2.2. By Application (Polymerase Chain Reaction, DNA Sequencing, DNA Cloning, Others)
    • 10.2.3. By End-use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers, Others)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa DNA Polymerase Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End-use
    • 10.3.2. Saudi Arabia DNA Polymerase Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End-use
    • 10.3.3. UAE DNA Polymerase Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End-use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global DNA Polymerase Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Product & Service Offerings
    • 15.1.3. Recent Developments
    • 15.1.4. Financials (If Listed)
    • 15.1.5. Key Personnel
    • 15.1.6. SWOT Analysis
  • 15.2. Agilent Technologies.
  • 15.3. Merck KGaA.
  • 15.4. Danaher Corp.
  • 15.5. QIAGEN N.V.
  • 15.6. Hoffmann-La Roche Ltd.
  • 15.7. Bio-Rad Laboratories, Inc.
  • 15.8. Takara Bio, Inc.
  • 15.9. Promega Corporation.
  • 15.10. New England Biolabs

16. Strategic Recommendations

17. About Us & Disclaimer